SPRC (scisparc.com) יחס שווי שוק לשווי בספרים

SciSparc Ltd (SPRC) automates the search for psychotropic compounds using robotics, accelerating the screening of formulas. The Israeli biotech's activities are focused on testing cannabinoids for autism therapy regardless of macroeconomic conditions. The team relies on the academic freedom of neurobiologists and stock option bonuses. A history of market value significantly exceeding book value clearly demonstrates volatility, where the value of 0.12 represents the current metric.

SciSparc Ltd (SPRC) possesses unique intellectual capital due to its stable roster of neurobiologists and clinical research experts. This metric measures the market value premium over net book value, filtering out market noise. Analyzing the excess of market valuation over book value allows current quotes to be correlated with tangible assets. This reveals trend reversals in the valuation of R&D potential. The stability of this metric confirms the high fundamental value of the company's protected scientific competencies.